GraniteShares Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Sell |
1,899
-211
| -10% | -$68.8K | 0.38% | 72 |
|
|
2025
Q1 | $570K | Sell |
2,110
-155
| -7% | -$41.9K | 0.36% | 71 |
|
|
2024
Q4 | $533K | Sell |
2,265
-454
| -17% | -$107K | 0.34% | 78 |
|
|
2024
Q3 | $748K | Sell |
2,719
-1,151
| -30% | -$317K | 0.51% | 71 |
|
|
2024
Q2 | $940K | Buy |
3,870
+693
| +22% | +$168K | 0.31% | 64 |
|
|
2024
Q1 | $475K | Buy |
3,177
+387
| +14% | +$57.8K | 0.25% | 88 |
|
|
2023
Q4 | $534K | Sell |
2,790
-103
| -4% | -$19.7K | 0.48% | 86 |
|
|
2023
Q3 | $512K | Buy |
+2,893
| New | +$512K | 0.48% | 79 |
|
|
2022
Q1 | – | Sell |
-595
| Closed | -$100K | – | 173 |
|
|
2021
Q4 | $100K | Buy |
+595
| New | +$100K | 0.05% | 270 |
|